AN ACT TO AMEND CHAPTER 170, VOLUME 84 OF THE LAWS OF DELAWARE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT AND DRUG TESTING STRIPS.

This bill removes the expiration date for Delaware's existing laws regarding xylazine, a drug often found in the opioid crisis. By deleting the specific clause that set the current regulations to end on November 29, 2024, the legislation ensures these rules remain in effect indefinitely. The changes directly impact state health officials and law enforcement who rely on these statutes to manage drug testing and control substance issues. Once signed by the governor, the state maintains its legal framework for addressing xylazine without needing to renew it annually.